2008 Summer Meeting
Implementing Evidence-Based Interventions to Improve the Treatment of Severe Sepsis: The ASHP Research and Education Foundation Award for Excellence in Medication-Use Safety Winner
Track: Hot Topic
Program Code:115-L05
Date: 10 June 2008
Time: Tuesday, June 10, 2008
Location:615 - Level 6MEETING PLANNING ASSOCIATE:
Dr. Cynthia LaCivita, PharmD, Director, Education and Special Programs, ASHP Research & Education Foundation
MODERATOR:
Dr. Cynthia LaCivita, PharmD, Director, Education and Special Programs, ASHP Research & Education Foundation
PRESENTER(S):
Dr. Craig McCammon, PharmD, BCPS, Clinical Pharmacist, Emergency Medicine, Barnes-Jewish Hospital
Craig A. McCammon is a Clinical Pharmacist in Emergency Medicine at Barnes-Jewish Hospital. He received his PharmD from UMKC in 1997. He completed a Pharmacy Practice Residency at Salt Lake City VA Medical Center and a Critical Care Residency at Barnes-Jewish Hospital. |
Dr. Scott Micek, PharmD, BCPS, Critical Care Pharmacist, Barnes-Jewish Hospital
Dr. Scott Micek is currently a clinical pharmacist in critical care at Barnes-Jewish Hospital in St. Louis, MO. Dr. Micek also holds an appointment as a clinical instructor and lecturer at the St. Louis College of Pharmacy. He currently serves as program director for the critical care specialty residency at Barnes-Jewish Hospital, and previously was the program director for the pharmacy practice residency. Dr. Micek earned his doctor of pharmacy degree at the University of Iowa, followed by a pharmacy practice residency at Barnes-Jewish Hospital. |
Description:
Worldwide 1,400 people die daily from severe sepsis. That number is expected to grow by 1.5% each year. Find out how Barnes-Jewish Hospital (BJH) effectively tackled their severe sepsis rates and mortality. By creating BJH-specific severe sepsis order sets, a framework that functioned as a lever for change was clearly articulated. Get the details in this session.
Learning Objectives:
- Describe an effective process for significantly reducing incidence and mortality of sepsis.
- Explain benefits of implementing this process.
- Identify challenges to implementing steps for the reduction of severe sepsis and how to effectively handle them.